Non-contact smart mattress for continuous monitoring of heart rate, breathing, temperature, and posture

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center clinical evaluation will test a mattress-shaped, non-invasive sensor system installed on standard hospital beds to record continuous heart rate, respiration, body temperature, and patient posture in adults admitted for cardiovascular disease. Monitoring data will be integrated with hospital information systems and patient-side digital platforms to support clinical management and remote follow-up. The mattress performance will be compared with routine monitoring approaches during inpatient care to determine accuracy and reliability before potential commercialization. Patients with severe acute conditions or those requiring mechanical ventilation are excluded from participation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adult inpatients (aged ≥18 years) admitted to the cardiovascular disease ward.
2. Willing to sign the informed consent form in person.
3. Capable of understanding and following the research instructions, as well as having the language ability to communicate and fill out the relevant questionnaires.

Exclusion Criteria:

1. The patient has an allergic reaction to any materials related to the research equipment or test materials (such as traditional monitoring instruments, mattress fibers, etc.).
2. There are serious diseases that require urgent medical intervention, such as hypertensive emergencies, acute myocardial infarction, acute heart failure, acute stroke, severe ventricular arrhythmias, and shock, etc.
3. The patient cannot cooperate with bed rest due to their condition or mental factors.
4. Severe respiratory diseases requiring mechanical assisted ventilation.
5. Patients requiring assistance from other medical electronic devices or instruments (such as temporary cardiac pacemakers, bedside hemodialysis, etc.).
6. The research team, after assessment, considers that there are other patients who do not meet the inclusion criteria.

Where it's running

• Beijing Anzhen Hospital, Capital Medical University
  Beijing, China, China Recruiting

Study contacts

• Principal investigator: Ning Zhou, Prof. — Beijing Anzhen Hospital
• Study coordinator: Liu He, PhD.
• Email: theliu@139.com
• Phone: +86 138-1072-0787

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease

  This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.

  Recruiting Odense University Hospital · Svendborg · NCT07878325

• Petrelintide for weight loss in people with overweight/obesity and heart disease

  This study tests whether petrelintide helps people with overweight or obesity and cardiovascular disease lose weight when added to a reduced-calorie diet and more physical activity, compared with a placebo.

  Recruiting at 3 sites Phase 3 Hoffmann-La Roche · Anniston, Alabama and 2 other locations · NCT07843472

• VERVE-102 for adults with or at high risk for heart disease

  This study tests whether VERVE-102 can lower bad cholesterol (LDL-C) compared with a placebo in adults with plaque buildup or high risk for it.

  Recruiting Phase 2 Verve Therapeutics, Inc. · DeSoto, Texas · NCT07839936

• Clazakizumab for adults with high hsCRP at risk for a heart event

  This study tests whether clazakizumab can lower inflammation and reduce cardiovascular risk in adults with high hsCRP and existing risk factors.

  Recruiting at 32 sites Phase 2 Eli Lilly and Company · Huntsville, Alabama and 45 other locations · NCT07783802

• Improving Care for underserved older Black patients with cardiovascular and other chronic conditions

  This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07748858

• 4D MRI parameters linked to cardiovascular and cancer disease outcomes

  This study tests whether 4D MRI measurements can predict how cardiovascular diseases and cancer will progress in adults undergoing routine cardiac MRI at a single Korean hospital.

  Recruiting Ulsan University Hospital · Ulsan, Ulsan · NCT07678606

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.